HiFiBiO
is a Massachusetts-based biotherapeutics company that discovers, develops and commercializes antibody drugs for the treatment of cancer and autoimmune diseases... Read moreHiFiBiO
is a Massachusetts-based biotherapeutics company that discovers, develops and commercializes antibody drugs for the treatment of cancer and autoimmune diseases... Read more
News
Nov 04, 2024
StreetInsider
Press Release: HiFiBiO : HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200604, a Best-in-Class BTLA Agonist Antibody for the Treatment of Inflammatory and Immunology Diseases
Aug 28, 2023
Business Wire
Press Release: HiFiBiO : Fierce Biotech Names HiFiBiO Therapeutics a "Fierce 15" Biotech Company of 2023
Jun 23, 2023
Medical Device News Magazine
HiFiBiO: HiFiBiO Therapeutics Announces First Patient Dosed with HFB200301 in Combination with tislelizumab in Patients with DIS Selected Advanced Solid Tumors
Apr 06, 2023
AZoM
HiFiBiO: Personalized Drug Discovery at Lightspeed
Jan 06, 2023
Acrofan
HiFiBiO: HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200603
Nov 17, 2022
Acrofan
HiFiBiO: HiFiBiO Therapeutics Announces Clinical Trial Supply Agreement to Evaluate HFB200603 in Combination with Tislelizumab in Patients with DIS Selected A
Dec 20, 2021
FirstWord PHARMA
HiFiBiO: FibroGen Exercises Exclusive License Option for HiFiBiO's CCR8 Program
Jun 24, 2021
Global Legal Chronicle
HiFiBiO: FibroGen's Partnership with HiFiBiO Therapeutics
Jun 19, 2021
Global Legal Chronicle
HiFiBiO: HiFiBiO's $75 Million Series D Financing Round
Jun 17, 2021
MarketScreener
HiFiBiO: FibroGen and HiFiBiO Announce Transformative Partnership to Advance Next-Generation Therapies for Patients with Cancer and Autoimmune Disease
HiFiBiO Competitors
1
2
3
4
5
6
7
8
9
10